Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Victor López de Rioja

3PUBLICATIONS

14CO-AUTHORS

Infant and child healthPredictive and prognostic markersRespiratory diseases

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Sep 28, 2024

Introduction of nirsevimab in Catalonia, Spain: description of the incidence of bronchiolitis and respiratory syncytial virus in the 2023/2024 season.

Aida Perramon-Malavez, Víctor López de Rioja, Ermengol Coma

|May 25, 2024

Severity of Omicron Subvariants and Vaccine Impact in Catalonia, Spain.

Víctor López de Rioja, Luca Basile, Aida Perramon-Malavez

|Jul 26, 2023

Unraveling the effects of the COVID-19 pandemic on the hospital burden of respiratory syncytial virus.

Aida Perramon-Malavez, Victor López de Rioja, Anna Creus-Costa

Pageof 1

Frequent Collaborators

3 joint publications

Aida Perramon-Malavez

3 joint publications

Clara Prats

2 joint publications

Cristina Montañola-Sales

2 joint publications

Antoni Soriano-Arandes

2 joint publications

Ermengol Coma

2 joint publications

Jacobo Mendioroz Peña

1 joint publications

Esther Lera

1 joint publications

Luca Basile

1 joint publications

Daniel López

1 joint publications

Sergio Medina Maestro

Frequent Collaborators

3 joint publications

Aida Perramon-Malavez

3 joint publications

Clara Prats

2 joint publications

Cristina Montañola-Sales

2 joint publications

Antoni Soriano-Arandes

Top Related Videos

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on : Jan 26, 2019

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Published on : Sep 08, 2023

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on : Dec 10, 2013

See more related videos

Top Related Videos

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on : Jan 26, 2019

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Published on : Sep 08, 2023

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on : Dec 10, 2013

See more related videos